Creative Medical Technology Holdings Inc (CELZ)
4.32
-0.08
(-1.82%)
USD |
NASDAQ |
Apr 26, 15:45
Creative Medical Technology Holdings Cash from Operations (TTM): -8.028M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.028M |
September 30, 2023 | -9.724M |
June 30, 2023 | -9.293M |
March 31, 2023 | -10.06M |
December 31, 2022 | -7.797M |
September 30, 2022 | -5.367M |
June 30, 2022 | -4.885M |
March 31, 2022 | -3.351M |
December 31, 2021 | -2.216M |
September 30, 2021 | -0.9975M |
June 30, 2021 | -0.7807M |
March 31, 2021 | -0.6808M |
December 31, 2020 | -0.4346M |
September 30, 2020 | -0.744M |
June 30, 2020 | -0.9282M |
March 31, 2020 | -1.135M |
December 31, 2019 | -1.213M |
September 30, 2019 | -1.256M |
June 30, 2019 | -1.245M |
March 31, 2019 | -1.160M |
December 31, 2018 | -1.052M |
September 30, 2018 | -0.8794M |
June 30, 2018 | -0.8061M |
March 31, 2018 | -0.8308M |
December 31, 2017 | -0.8896M |
Date | Value |
---|---|
September 30, 2017 | -0.9523M |
June 30, 2017 | -0.7995M |
March 31, 2017 | -0.6333M |
December 31, 2016 | -0.4452M |
September 30, 2016 | -0.2618M |
June 30, 2016 | -0.1433M |
March 31, 2016 | -0.0449M |
December 31, 2015 | -0.0146M |
September 30, 2015 | -0.018M |
June 30, 2015 | -0.0183M |
March 31, 2015 | -0.0186M |
December 31, 2014 | -0.0173M |
September 30, 2014 | -0.0163M |
June 30, 2014 | -0.0173M |
March 31, 2014 | -0.018M |
December 31, 2013 | -0.0229M |
September 30, 2013 | -0.0218M |
June 30, 2013 | -0.0221M |
March 31, 2013 | -0.0188M |
December 31, 2012 | -0.0168M |
September 30, 2012 | -0.0136M |
June 30, 2012 | -0.0149M |
March 31, 2012 | -0.0172M |
December 31, 2011 | -0.014M |
September 30, 2011 | -0.0167M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.06M
Minimum
Mar 2023
-0.4346M
Maximum
Dec 2020
-3.692M
Average
-1.256M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
Avid Bioservices Inc | 12.68M |
Viking Therapeutics Inc | -54.87M |
Avinger Inc | -14.43M |
Aptevo Therapeutics Inc | -11.73M |
Absci Corp | -64.64M |